DNMT3A Human siRNA Oligo Duplex (Locus ID 1788)
CAT#: SR319937
DNMT3A (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each
Need single siRNA in bulk?
Get a free quote
SR319937 is the updated version of SR301246.
CNY 4,090.00
货期*
4周
规格
Cited in 4 publications. |
Product images
经常一起买 (3)
Specifications
Product Data | |
Purity | HPLC purified |
Quality Control | Tested by ESI-MS |
Sequences | Available with shipment |
Stability | One year from date of shipment when stored at -20°C. |
# of transfections | Approximately 330 transfections/2nmol in 24-well plate under optimized conditions (final conc. 10 nM). |
Note | Single siRNA duplex (10nmol) can be ordered. |
Reference Data | |
RefSeq | NM_001320892, NM_001320893, NM_022552, NM_153759, NM_175629, NM_175630, NR_135490 |
Synonyms | DNMT3A2; HESJAS; M.HsaIIIA; TBRS |
Components | DNMT3A (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each (Locus ID 1788)Included - SR30004, Trilencer-27 Universal Scrambled Negative Control siRNA Duplex - 2 nmolIncluded - SR30005, RNAse free siRNA Duplex Resuspension Buffer - 2 ml |
Summary | CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase that is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes to the cytoplasm and nucleus and its expression is developmentally regulated. [provided by RefSeq, Mar 2016] |
Performance Guranteed | OriGene guarantees that at least two of the three Dicer-Substrate duplexes in the kit will provide at least 70% or more knockdown of the target mRNA when used at 10 nM concentration by quantitative RT-PCR when the TYE-563 fluorescent transfection control duplex (cat# SR30002) indicates that >90% of the cells have been transfected and the HPRT positive control (cat# SR30003) provides 90% knockdown efficiency. For non-conforming siRNA, requests for replacement product must be made within ninety (90) days from the date of delivery of the siRNA kit. To arrange for a free replacement with newly designed duplexes, please contact Technical Services at techsupport@origene.com. Please provide your data indicating the transfection efficiency and measurement of gene expression knockdown compared to the scrambled siRNA control (quantitative RT-PCR data required). |
Citations (4)
The use of this RNAi has been cited in the following citations: |
---|
Cyclic AMP Response Element Modulator-α Suppresses PD-1 Expression and Promotes Effector CD4+ T Cells in Psoriasis
,Hofmann, SR;Carlsson, E;Kapplusch, F;Carvalho, AL;Liloglou, T;Schulze, F;Abraham, S;Northey, S;Russ, S;Surace, AEA;Yoshida, N;Tsokos, GC;Hedrich, CM;,
Journal of immunology (Baltimore, Md. : 1950) 2021
,PubMed ID 34135066
[DNMT3A]
|
Prognostic significance of DNMT3A alterations in Middle Eastern papillary thyroid carcinoma
,Siraj, A;Pratheeshkumar, P;Parvathareddy, S;Bu, R;Masoodi, T;Iqbal, K;Al-Rasheed, M;Al-Dayel, F;Al-Sobhi, S;Alzahrani, A;Al-Dawish, M;Al-Kuraya, K;,
European Journal of Cancer
,PubMed ID 31280122
[DNMT3A]
|
LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation
,Cheng, D;Deng, J;Zhang, B;He, X;Meng, Z;Li, G;Ye, H;Zheng, S;Wei, L;Deng, X;Chen, R;Zhou, J;,
EBioMedicine
,PubMed ID 30195653
[DNMT3A]
|
Benzo[a]pyrene diol epoxide suppresses retinoic acid receptor-?2 expression by recruiting DNA (cytosine-5-)-methyltransferase 3A
,null,
Molecular Cancer
,PubMed ID 20426865
[DNMT3A]
|
Documents
Product Manuals |
FAQs |
SDS |
Customer
Reviews
Loading...